205 related articles for article (PubMed ID: 17940133)
1. Effects of chronic renal failure on liver drug transporters.
Naud J; Michaud J; Leblond FA; Lefrancois S; Bonnardeaux A; Pichette V
Drug Metab Dispos; 2008 Jan; 36(1):124-8. PubMed ID: 17940133
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of intestinal drug transporters in chronic renal failure in rats.
Naud J; Michaud J; Boisvert C; Desbiens K; Leblond FA; Mitchell A; Jones C; Bonnardeaux A; Pichette V
J Pharmacol Exp Ther; 2007 Mar; 320(3):978-85. PubMed ID: 17135344
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic renal failure on brain drug transporters in rats.
Naud J; Laurin LP; Michaud J; Beauchemin S; Leblond FA; Pichette V
Drug Metab Dispos; 2012 Jan; 40(1):39-46. PubMed ID: 21969519
[TBL] [Abstract][Full Text] [Related]
5. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure.
Laouari D; Yang R; Veau C; Blanke I; Friedlander G
Am J Physiol Renal Physiol; 2001 Apr; 280(4):F636-45. PubMed ID: 11249855
[TBL] [Abstract][Full Text] [Related]
6. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
7. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats.
Cherrington NJ; Slitt AL; Li N; Klaassen CD
Drug Metab Dispos; 2004 Jul; 32(7):734-41. PubMed ID: 15205389
[TBL] [Abstract][Full Text] [Related]
9. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
[TBL] [Abstract][Full Text] [Related]
10. Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine.
Guo Y; Jiang L
Neurol Res; 2010 Feb; 32(1):106-12. PubMed ID: 19570321
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.
Guévin C; Michaud J; Naud J; Leblond FA; Pichette V
Br J Pharmacol; 2002 Dec; 137(7):1039-46. PubMed ID: 12429576
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic drug transporter activity and expression by organochlorine pesticides.
Bucher S; Le Vee M; Jouan E; Fardel O
J Biochem Mol Toxicol; 2014 Mar; 28(3):119-28. PubMed ID: 24464585
[TBL] [Abstract][Full Text] [Related]
13. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
14. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
15. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
[TBL] [Abstract][Full Text] [Related]
16. Functional ATP-binding cassette drug efflux transporters in isolated human and rat hepatocytes significantly affect assessment of drug disposition.
Lundquist P; Englund G; Skogastierna C; Lööf J; Johansson J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):448-58. PubMed ID: 24396144
[TBL] [Abstract][Full Text] [Related]
17. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
18. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
[TBL] [Abstract][Full Text] [Related]
19. Decreased in vivo metabolism of drugs in chronic renal failure.
Leblond FA; Giroux L; Villeneuve JP; Pichette V
Drug Metab Dispos; 2000 Nov; 28(11):1317-20. PubMed ID: 11038159
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Four Efflux Drug Transporters in Liver and Kidney Across Species Using Targeted Quantitative Proteomics by Isotope Dilution NanoLC-MS/MS.
Fallon JK; Smith PC; Xia CQ; Kim MS
Pharm Res; 2016 Sep; 33(9):2280-8. PubMed ID: 27356525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
